AI-powered medical search engine that delivers synthesized, cited answers from peer-reviewed research for clinicians.
Personalized Analysis and Treatment of Heart Disease
13KMonthly visits
19Popularity
About Personalized Analysis and Treatment of Heart Disease
Cleerly is an AI-driven medical platform designed to analyze coronary CT angiography scans to detect, quantify, and characterize coronary artery disease. The system uses a fine-tuned foundation model to provide detailed, patient-specific assessments of plaque buildup, stenosis severity, and overall cardiovascular risk. Clinicians can use Cleerly to generate automated reports that highlight areas of concern, reducing manual interpretation time and improving diagnostic accuracy. The platform supports shared decision-making by offering tailored treatment recommendations based on the AI analysis. It is intended for cardiologists, radiologists, and other healthcare professionals involved in cardiovascular care. Cleerly integrates into existing clinical workflows, enabling faster and more consistent evaluation of coronary artery disease compared to traditional methods. The tool is particularly valuable in settings where high-volume CT imaging requires efficient and reproducible analysis.
Key features
- Automated coronary artery plaque detection and quantification
- Stenosis severity assessment with AI-generated measurements
- Personalized treatment recommendations based on scan findings
- Integration with existing clinical workflows and imaging systems
- Detailed, structured reports for cardiologists and radiologists
- Support for shared decision-making in cardiovascular care
- Fine-tuned foundation model for high accuracy in coronary analysis
- Reduces manual interpretation time for CT angiography scans
Use cases
- Automated analysis of coronary CT scans for suspected coronary artery disease
- Quantification of plaque burden and stenosis in high-risk patients
- Supporting cardiologists in developing personalized treatment plans
Pros
- Provides comprehensive quantification of coronary artery disease (CAD) by measuring plaque volume, composition, length, and location
- Evaluates stenosis severity in both 2D and 3D, enhancing diagnostic precision
- Demonstrates higher diagnostic accuracy compared to FFRCT and stress testing in clinical trials
- Offers workflow for determining likely presence or absence of ischemia, potentially reducing additional testing
- Delivers clinically actionable insights through a web-based solution for healthcare providers
Cons
- Requires integration into existing clinical workflows, which may involve training and adaptation
- Dependent on high-quality coronary CT angiography (CCTA) scans for accurate analysis
Frequently asked questions about Personalized Analysis and Treatment of Heart Disease
What does Cleerly do?
Cleerly is an AI-driven platform that analyzes coronary CT angiography scans to quantify and assess coronary artery disease, providing detailed insights on plaque characteristics, stenosis severity, and potential ischemia.
Who is Cleerly designed for?
The platform is intended for cardiologists, radiologists, and other healthcare professionals involved in cardiovascular care who need accurate and efficient analysis of coronary artery disease.
How does Cleerly integrate into clinical workflows?
Cleerly provides automated reports and tailored treatment recommendations based on AI analysis, reducing manual interpretation time and supporting shared decision-making in patient care.
Does Cleerly require additional testing for patients?
The platform aims to reduce the need for additional testing by providing comprehensive insights on plaque and stenosis, potentially improving diagnostic confidence without further procedures.
What evidence supports Cleerly's accuracy?
Cleerly ISCHEMIA demonstrated higher diagnostic accuracy in the CREDENCE trial and outperformed other non-invasive tests in predicting future major adverse cardiac events (MACE) in the PACIFIC study.
How can healthcare providers get started with Cleerly?
Providers can request a demo or contact Cleerly to explore implementation, integration, and workflow adaptation for their practice.
Personalized Analysis and Treatment of Heart Disease Website Engagement
Last Update: 9 days ago
Total Monthly Visits
0
Bounce Rate
0%
Visit Duration (avg)
0.00s
Pages Per Visit
0
Country Rank
0
United States
Global Rank
0
Category Rank
#0
Health
Monthly Traffic
Traffic Sources
Traffic Share By Country
- United States82.9%
- Philippines5.8%
- Canada4.5%
- India4%
- Brazil1.6%
